Expression and manufacture of pharmaceutical proteins in genetically engineered horticultural plants

Transgenic Horticultural Crops: Challenges and Opportunities

Volumn , Issue , 2011, Pages 83-124

  Chen, Qiang ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84975089176     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (264)

1. Farnsworth, N.R. et al., Medicinal plants in therapy, Bull World Health Organ, 63, 965, 1985.
2. Duke, J., Medicinal plants and the pharmaceutical industry, in New crops, Janick, J. and Simon, J. Eds., Wiley, New York, 1993, 664.
3. Ma, J., Drake, P., and Christou, P., The production of recombinant pharmaceutical proteins in plants, Nat Rev Genet, 4, 794, 2003.
4. Barta, A. et al., The expression of a nopaline synthase—Human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue, Plant Mol Biol, 6, 347, 1986.
5. Hiatt, A., Cafferkey, R., and Bowdish, K., Production of antibodies in transgenic plants, Nature, 342, 76, 1989.
6. Mason, H.S., Lam, D.M., and Arntzen, C.J., Expression of hepatitis B surface antigen in transgenic plants, Proc Natl Acad Sci USA, 89, 11745, 1992.
7. Haq, T.A. et al., Oral immunization with a recombinant bacterial antigen produced in transgenic plants, Science, 268, 714, 1995.
8. Yin, J. et al., Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes, J Biotechnol, 127, 335, 2007.
9. Kostandini, G., Mills, B.F., and Norton, G.W., The potential impact of tobacco biopharming: The case of human serum albumin, Am J Agr Econ, 88, 671, 2006.
10. Hood, E.E., Woodard, S.L., and Horn, M.E., Monoclonal antibody manufacturing in transgenic plants—Myths and realities, Curr Opin Biotechnol, 13, 630, 2002.
11. Giddings, G., Transgenic plants as protein factories, Curr Opin Biotechnol, 12, 450, 2001.
12. Nandi, S. et al., Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain, Transgenic Res, 14, 237, 2005.
13. Chen, Q., Expression and purification of pharmaceutical proteins in plants. Biol Eng, 1, 291, 2008.
14. Vitale, A. and Pedrazzini, E., Recombinant pharmaceuticals from plants: The plant endomembrane system as bioreactor, Mol Interv, 5, 216, 2005.
15. Hansen, G. and Wright, M.S., Recent advances in the transformation of plants, Trends Plant Sci, 4, 226, 1999.
16. Lico, C., Chen, Q., and Santi, L., Viral vectors for production of recombinant proteins in plants, J Cell Physiol, 216, 366, 2008.
17. Porta, C. et al., Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses, Virology, 310, 50, 2003.
18. Lico, C. et al., Peptide display on Potato virus X: Molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles, J Gen Virol, 87, 3103, 2006.
19. Scholthof, H.B., Morris, T.J., and Jackson, A.O., The capsid protein gene of tomato bushy stunt virus is dispensable for systemic movement and can be replaced for localized expression of foreign genes, Mol Plant–Microbe Interact, 6, 309, 1993.
20. Musiychuk, K. et al., A launch vector for the production of vaccine antigens in plants, Influenza, 1, 19, 2007.
21. Huang, Z. et al., High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system, Biotechnol Bioeng, 106, 9, 2010.
22. Gleba, Y., Klimyuk, V., and Marillonnet, S., Magnifection—A new platform for expressing recombinant vaccines in plants, Vaccine, 23, 2042, 2005.
23. Giritch, A. et al., Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors, Proc Natl Acad Sci USA, 103, 14701, 2006.
24. Marillonnet, S. et al., In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium, Proc Natl Acad Sci USA, 101, 6852, 2004.
25. McCarthy, A.A., Biolex, Inc.: Pharmaceutical production in plants, Chem Biol, 12, 141, 2005.
26. Baulcombe, D., Overview of RNA interference and related processes, Curr Protoc Mol Biol, 26, 1, 2003.
27. Baulcombe, D., RNA silencing in plants, Nature, 431, 356, 2004.
28. Baulcombe, D., RNA silencing, Trends Biochem Sci, 30, 290, 2005.
29. Baulcombe, D.C., Short silencing RNA: The dark matter of genetics? Cold Spring Harb Symp Quant Biol, 71, 13, 2006.
30. Baulcombe, D.C., Molecular biology: Amplified silencing, Science, 315, 199, 2007.
31. Baulcombe, D.C. and Molnar, A., Crystal structure of p19—a universal suppressor of RNA silencing, Trends Biochem Sci, 29, 279, 2004.
32. Daniell, H., Chloroplast genetic engineering, Biotechnol J, 1, 31, 2006.
33. Daniell, H., Production of biopharmaceuticals and vaccines in plants via the chloroplast genome, Biotechnol J, 1, 1071, 2006.
34. Daniell, H. et al., Chloroplast-derived vaccine antigens and other therapeutic proteins, Vaccine, 23, 1779, 2005.
35. Ruf, S., Karcher, D., and Bock, R., Determining the transgene containment level provided by chloroplast transformation, Proc Natl Acad Sci USA, 104, 6998, 2007.
36. Daniell, H., Khan, M., and Allison, L., Milestones in chloroplast genetic engineering: An environmentally friendly era in biotechnology, Trends Plant Sci, 7, 84, 2002.
37. Pavlou, A.K. and Belsey, M.J., The therapeutic antibodies market to 2008, Eur J Pharm Biopharm, 59, 389, 2005.
38. Monocolonal Antibodies 2007: Competitive Landscape & Pipeline Insight. Market Research Report, January 2007, 158 pp. Arrowhead Publishers, Minneapolis, MN.
39. Mclean, M.D. et al., A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro, Antimicrob Agents Chemother, 51, 3322, 2007.
40. Ko, K. et al., Inhibition of tumor growth by plant-derived mAb, Proc Natl Acad Sci USA, 102, 7026, 2005.
41. Kelley, B., Very large scale monoclonal antibody purification: The case for conventional unit operations, Biotechnol Prog, 23, 995, 2007.
42. Sack, M. et al., Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures, FASEB J, 21, 1655, 2007.
43. Ma, J. et al., Generation and assembly of secretory antibodies in plants, Science, 268, 716, 1995.
44. Peeters, K., De Wilde, C., and Depicker, A., Highly efficient targeting and accumulation of a Fab fragment within the secretory pathway and apoplast of Arabidopsis thaliana, Eur J Biochem, 268, 4251, 2001.
45. Ko, K. et al., Function and glycosylation of plant-derived antiviral monoclonal antibody, Proc Natl Acad Sci USA, 100, 8013, 2003.
46. Ludwig, D. et al., Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed, Human Antibodies, 13, 81, 2004.
47. Hull, A.K. et al., Human-derived, plant-produced monoclonal antibody for the treatment of anthrax, Vaccine, 23, 2082, 2005.
48. Makvandi-Nejad, S. et al., Transgenic tobacco plants expressing a dimeric single-chain variable fragment (scFv) antibody against Salmonella enterica serotype paratyphi B, Transgenic Res, 14, 785, 2005.
49. Galeffi, P. et al., Expression of single-chain antibodies in transgenic plants, Vaccine, 23, 1823, 2005.
50. Almquist, K.C. et al., Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco, Vaccine, 24, 2079, 2006.
51. Alamillo, J.M. et al., Use of virus vectors for the expression in plants of active full-length and single chain anti-coronavirus antibodies, Biotechnol J, 1, 1103, 2006.
52. Semenyuk, E.G. et al., Expression of single-chain antibody-barstar fusion in plants, Biochimie, 89, 31, 2007.
53. Jin, C. et al., A plant derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits, Glycobiology, 18, 235, 2008.
54. Van Droogenbroeck, B. et al., Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds, Proc Natl Acad Sci USA, 104, 1430, 2007.
55. Brodzik, R. et al., Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells, Proc Natl Acad Sci USA, 103, 8804, 2006.
56. Pujol, M. et al., Fighting cancer with plant-expressed pharmaceuticals, Trends Biotechnol, 25, 455, 2007.
57. Gomord, V. et al., Production and glycosylation of plant-made pharmaceuticals: The antibodies as a challenge, Plant Biotechnol J, 2, 83, 2004.
58. Lai, H. et al., Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice, Proc Natl Acad Sci USA, 107, 2419, 2010.
59. Zeitlin, L. et al., Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina, J Reprod Immunol, 40, 93, 1998.
60. Vaquero, C. et al., A carcinoembryonic antigen-specific diabody produced in tobacco, FASEB J, 16, 408, 2002.
61. Bouquin, T. et al., Human anti-rhesus D IgG1 antibody produced in transgenic plants, Transgenic Res, 11, 115, 2002.
62. Yano, A., Maeda, M., and Takekoshi, M., Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen, J Med Virol, 73, 208, 2004.
63. Fischer, R., Twyman, R.M., and Schillberg, S., Production of antibodies in plants and their use for global health, Vaccine, 21, 820, 2003.
64. Ramessar, K. et al., Cost-effective production of a vaginal protein microbicide to prevent HIV transmission, Proc Natl Acad Sci USA, 105, 3727, 2008.
65. Mccormick, A.A. et al., Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants, Proc Natl Acad Sci USA, 96, 703, 1999.
66. Mccormick, A.A. et al., Individualized human scFv vaccines produced in plants: Humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig, J Immunol Methods, 278, 95, 2003.
67. Mccormick, A.A. et al., Plant-produced idiotype vaccines for the treatment of non-Hodgkin’s lymphoma: Safety and immunogenicity in a phase I clinical study, Proc Natl Acad Sci USA, 105, 10131, 2008.
68. Vaquero, C. et al., Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves, Proc Natl Acad Sci USA, 96, 11128, 1999.
69. Kathuria, S. et al., Efficacy of plant-produced recombinant antibodies against HCG, Hum Reprod, 17, 2054, 2002.
70. Dietrich, C. and Maiss, E., Fluorescent labelling reveals spatial separation of potyvirus populations in mixed infected Nicotiana benthamiana plants, J Gen Virol, 84, 2871, 2003.
71. Diveki, Z., Salanki, K., and Balazs, E., Limited utility of blue fluorescent protein (BFP) in monitoring plant virus movement, Biochimie, 84, 997, 2002.
72. Hull, R. and Plaskitt, A., Electron microscopy on the behavior of two strains of alfalfa mosaic virus in mixed infections, Virology, 42, 773, 1970.
73. Marillonnet, S. et al., Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants, Nat Biotechnol, 23, 718, 2005.
74. Latham, T. and Galarza, J.M., Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins, J Virol, 75, 6154, 2001.
75. Pushko, P. et al., Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza, Vaccine, 25, 4283, 2007.
76. Sainsbury, F. and Lomonossoff, G.P., Extremely high-level and rapid transient protein production in plants without the use of viral replication, Plant Physiol, 148, 1212, 2008.
77. Chen, Q. et al., Subunit vaccines produced using plant biotechnology, in New Generation Vaccines, Levine, M.M. Ed., 4th edn. Informa Healthcare USA, Inc., New York, 2009, p. 306.
78. Denis, J. et al., Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform, Vaccine, 26, 3395, 2008.
79. Yusibov, V. et al., Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1, Proc Natl Acad Sci USA, 94, 5784, 1997.
80. Marusic, C. et al., Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1, J Virol, 75, 8434, 2001.
81. Richter, L.J. et al., Production of hepatitis B surface antigen in transgenic plants for oral immunization, Nat Biotechnol, 18, 1167, 2000.
82. Gao, Y. et al., gd T cells provide an early source of IFN-g in tumor immunity, J Exp Med, 198, 433, 2003.
83. Gomez, N. et al., Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus, Arch Virol, 145, 1725, 2000.
84. Tuboly, T. et al., Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants, Vaccine, 18, 2023, 2000.
85. Chikwamba, R. et al., A functional antigen in a practical crop: Maize synthesizes LT-B protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT), Transgenic Res, 11, 479, 2002.
86. Streatfield, S.J. et al., Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli, In Vitro Cell Dev Biol Plant, 38, 11, 2002.
87. Carrillo, C. et al., Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants, Viral Immunol, 14, 49, 2001.
88. Dus Santos, M.J. et al., Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen, Vaccine, 23, 1838, 2005.
89. Gilleland, H.E. et al., Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection, FEMS Immunol Med Microbiol, 27, 291, 2000.
90. Staczek, J. et al., Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa, Vaccine, 18, 2266, 2000.
91. Yusibov, V. et al., Peptide-based candidate vaccine against respiratory syncytial virus, Vaccine, 23, 2261, 2005.
92. Saldana, S. et al., Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies, Viral Immunol, 19, 42, 2006.
93. Matsumura, T., Itchoda, N., and Tsunemitsu, H., Production of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants, Arch Virol, 147, 1263, 2002.
94. Webster, D.E. et al., Measles virus hemagglutinin protein expressed in transgenic lettuce induces neutralising antibodies in mice following mucosal vaccination, Vaccine, 24, 3538, 2006.
95. Webster, D.E. et al., The development of a plant-based vaccine for measles, Vaccine, 23, 1859, 2005.
96. Ghosh, S. et al., Expression of Plasmodium falciparum C-terminal region of merozoite surface protein (PfMSP119), a potential malaria vaccine candidate, in tobacco, Plant Sci, 162, 335, 2002.
97. Wang, L. et al., Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants, Int J Parasitol, 38, 103, 2008.
98. Li, J.-T. et al., Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations, Virology, 356, 171, 2006.
99. Santi, L. et al., Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system, Proc Natl Acad Sci USA, 103, 861, 2006.
100. Mett, V. et al., A plant-produced plague vaccine candidate confers protection to monkeys, Vaccine, 25, 3014, 2007.
101. Saejung, W. et al., Production of dengue 2 envelope domain III in plant using TMV-based vector system, Vaccine, 25, 6646, 2007.
102. Dorokhov, Y.L. et al., Superexpression of tuberculosis antigens in plant leaves, Tuberculosis, 87, 218, 2007.
103. Massa, S. et al., Anti-cancer activity of plant-produced HPV16 E7 vaccine, Vaccine, 25, 3018, 2007.
104. Golovkin, M. et al., Smallpox subunit vaccine produced in Planta confers protection in mice, Proc Natl Acad Sci USA, 104, 6864, 2007.
105. Phelps, J.P., Dang, N., and Rasochova, L., Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis, J Virol Methods, 141, 146, 2007.
106. Chichester, J.A. et al., Immunogenicity of a subunit vaccine against Bacillus anthracis, Vaccine, 25, 3111, 2007.
107. Mor, T.S., Gomez-Lim, M.A., and Palmer, K.E., Perspective: Edible vaccines—A concept coming of age, Trends Microbiol, 6, 449, 1998.
108. Ogra, P.L., Faden, H., and Welliver, R.C., Vaccination strategies for mucosal immune responses, Clin Microbiol Rev, 14, 430, 2001.
109. Czerkinsky, C. et al., Mucosal immunity and tolerance: Relevance to vaccine development, Immunol Rev, 170, 197, 1999.
110. Mestecky, J. et al., Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans, Behring Inst Mitt, 98, 33, 1997.
111. Zivny, J.H. et al., Mechanisms of immune tolerance to food antigens in humans, Clin Immunol, 101, 158, 2001.
112. Hathaway, L.J. and Kraehenbuhl, J.P., The role of M cells in mucosal immunity, Cell Mol Life Sci, 57, 323, 2000.
113. De Magistris, M.T., Mucosal delivery of vaccine antigens and its advantages in pediatrics, Adv Drug Delivery Rev, 58, 52, 2006.
114. Eriksson, K. and Holmgren, J., Recent advances in mucosal vaccines and adjuvants, Curr Opin Immunol, 14, 666, 2002.
115. Streatfield, S.J., Mucosal immunization using recombinant plant-based oral vaccines, Methods, 38, 150, 2006.
116. Nochi, T. et al., From the cover: Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination, Proc Natl Acad Sci USA, 104, 10986, 2007.
117. Santi, L. et al., An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles, Vaccine, 26, 1846, 2008.
118. Moravec, T. et al., Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine, Vaccine, 25, 1647, 2007.
119. Dong, J.-L. et al., Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection, Virology, 339, 153, 2005.
120. Choi, N.-W., Estes, M.K., and Langridge, W.H.R., Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response, J Biotechnol, 121, 272, 2006.
121. Shin, E.-A. et al., Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants, Protein Expr Purif, 47, 99, 2006.
122. Walmsley, A.M., Krik, D.D., and Mason, H.S., Passive immunization of mice pups through oral immunization of dams with a plant-derived vaccine, Immunology, 86, 71, 2003.
123. Tacket, C.O. et al., Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn, Vaccine, 22, 4385, 2004.
124. Kapusta, J. et al., A plant-derived edible vaccine against hepatitis B vaccine, FASEB J, 13, 1796, 1999.
125. Yusibov, V. et al., Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine, Vaccine, 20, 3155, 2002.
126. Streatfield, S.J., Approaches to achieve high-level heterologous protein production in plants, Plant Biotechnol J, 5, 2, 2007.
127. Takagi, H. et al., From the cover: A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses, Proc Natl Acad Sci USA, 102, 17525, 2005.
128. Takaiwa, F., A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit allergy, Immunol Allergy Clin North Am, 27, 129, 2007.
129. Yu, J. and Langridge, W.H., A plant-based multicomponent vaccine protects mice from enteric diseases, Nat Biotechnol, 19, 548, 2001.
130. Herbst-Kralovetz, M., Mason, H.S., and Chen, Q., Norwalk virus-like particles as vaccines, Expert Rev Vaccines 9, 299, 2010.
131. Nemchinov, L.G. and Natilla, A., Transient expression of the ectodomain of matrix protein 2 (M2e) of avian influenza A virus in plants, Protein Expr Purif, 56, 153–159, 2007.
132. Chargelegue, D. et al., A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice, Transgenic Res, 9, 187, 2000.
133. Saint-Jore-Dupas, C., Faye, L., and Gomord, V., From planta to pharma with glycosylation in the toolbox, Trends Biotech, 25, 317, 2007.
134. Schahs, M. et al., Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern, Plant Biotechnol J, 5, 657, 2007.
135. Strasser, R. et al., Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure, Plant Biotechnol J, 6, 392, 2008.
136. Cox, K.M. et al., Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor, Nat Biotechnol, 24, 1591, 2006.
137. Castilho, A. et al., Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis, Plant Physiol, 147, 331, 2008.
138. Castilho, A. et al., In planta protein sialylation through overexpression of the respective mammalian pathway, J Bio Chem, 285, 15923, 2010.
139. Kaiser, J., Is the drought over for pharming? Science, 320, 473, 2008.
140. Roque, A.C.A., Lowe, C.R., and Taipa, M.A., Antibodies and genetically engineered related molecules: Production and purification, Biotechnol Prog, 20, 639, 2004.
141. Nikolov, Z.L. and Woodard, S.L., Downstream processing of recombinant proteins from transgenic feedstock, Curr Opin Biotechnol, 15, 479, 2004.
142. Menkhaus, T.J. et al., Considerations for the recovery of recombinant proteins from plants, Biotechnol Prog, 20, 1001, 2004.
143. Platis, D. and Labrou, N.E., Affinity chromatography for the purification of therapeutic proteins from transgenic maize using immobilized histamine, J Sep Sci, 31, 636, 2008.
144. Langone, J.J., Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci, Adv Immunol, 32, 157, 1982.
145. Werner, S. et al., Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A, Proc Natl Acad Sci USA, 103, 17678, 2006.
146. Low, D., O’leary, R., and Pujar, N.S., Future of antibody purification, J Chromatogr B, 848, 48, 2007.
147. Valdes, R. et al., Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants, Biochem Biophys Res Commun, 308, 94, 2003.
148. Bai, Y. and Glatz, C.E., Bioprocess considerations for expanded-bed chromatography of crude canola extract: Sample preparation and adsorbent reuse, Biotechnol Bioeng, 81, 775, 2003.
149. Platis, D. and Labrou, N.E., Development of an aqueous two-phase partitioning system for fractionating therapeutic proteins from tobacco extract, J Chromatogr A, 1128, 114, 2006.
150. Balasubramaniam, D. et al., Tobacco protein separation by aqueous two-phase extraction, J Chromatogr A, 989, 119, 2003.
151. Vilter, H., Aqueous two-phase extraction of plant enzymes from sources containing large amounts of tannins and anionic mucilages, Bioseparation, 1, 283, 1990.
152. Miller, K., Gao, J., and Hooker, B.S., Initial clarification by aqueous two-phase partitioning of leaf extracts from Solanum tuberosum plants expressing recombinant therapeutic proteins, Bioprocessing J, 47, 2004.
153. Hahn, R. et al., Comparison of protein A affinity sorbents III—Life time study, J Chromatogr A, 1102, 224, 2006.
154. Kushwaha, A. et al., Construction and characterization of M13 bacteriophages displaying functional IgG-binding domains of Staphylococcal protein A, Gene, 151, 45, 1994.
155. Djojonegoro, B.M., Benedik, M.J., and Willson, R.C., Bacteriophage surface display of an immunoglobulin-binding domain of Staphylococcus aureus protein A, Biotechnology, 12, 169, 1994.
156. Moll, D. et al., S-layer-streptavidin fusion proteins as template for nanopatterned molecular arrays, Proc Natl Acad Sci USA, 99, 14646, 2002.
157. Vollenkle, C. et al., Construction of a functional S-layer fusion protein comprising an immunoglobulin G-binding domain for development of specific adsorbents for extracorporeal blood purification, Appl Environ Microbiol, 70, 1514, 2004.
158. Ramirez, C. et al., A bifunctional affinity linker to couple antibodies to cellulose, Nat Biotech, 11, 1570, 1993.
159. Shpigel, E. et al., Expression, purification and applications of staphylococcal protein A fused to cellulose-binding domain, Biotechnol Appl Biochem, 31 197, 2000.
160. Ji, Q. et al., Microbial starch-binding domains as a tool for targeting proteins to granules during starch biosynthesis, Plant Mol Biol, 51, 789, 2003.
161. Van Rooijen, G., and Moloney, M.M., Plant seed oil-bodies as carriers for foreign proteins, Nat Biotechnol, 13, 72, 1995.
162. Capuano, F. et al., Properties and exploitation of oleosins, Biotechnol Adv, 25, 203, 2007.
163. Ling, H., Oleosin fusion expression systems for the production of recombinant proteins, Biologia, 62, 119, 2007.
164. Roque, A.C.A., Silva, C.S.O., and Taipa, M.Â., Affinity-based methodologies and ligands for antibody purification: Advances and perspectives, J Chromatogr A, 1160, 44, 2007.
165. Schwartz, W. et al., Comparison of hydrophobic charge induction chromatography with affinity chromatography on protein A for harvest and purification of antibodies, J Chromatogr A, 908, 251, 2001.
166. Ghose, S., Hubbard, B., and Cramer, S.M., Evaluation and comparison of alternatives to protein A chromatography: Mimetic and hydrophobic charge induction chromatographic stationary phases, J Chromatogr A, 1122, 144, 2006.
167. Ghose, S. et al., Antibody variable region interactions with Protein A: Implications for the development of generic purification processes, Biotech Bioeng, 92, 665, 2005.
168. Roque, A.C.A., Taipa, M.Â., and Lowe, C.R., An artificial protein L for the purification of immunoglobulins and Fab fragments by affinity chromatography, J Chromatogr A, 1064, 157, 2005.
169. Arnau, J. et al., Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins, Protein Expr Purif, 48, 1, 2006.
170. Lichty, J.J. et al., Comparison of affinity tags for protein purification, Protein Expr Purif, 41, 98, 2005.
171. Tagwerker, C. et al., A tandem affinity tag for two-step purification under fully denaturing conditions: Application in ubiquitin profiling and protein complex identification combined with in vivocross-linking, Mol Cell Proteomics, 5, 737, 2006.
172. Lawrence, S., Novak, N., and Slack, J., Epitope tagging: A monoclonal antibody specific for recombinant fusion proteins in plants, Biotechniques, 35, 488, 2003.
173. Terpe, K., Overview of tag protein fusions: From molecular and biochemical fundamentals to commercial systems, Appl Microbiol Biotechnol, 60, 523, 2003.
174. Kwon, S. et al., Isolation of the Arabidopsis phosphoproteome using a biotin-tagging approach, Mol Cells, 24, 268, 2007.
175. Witte, C.-P. et al., Rapid one-step protein purification from plant material using the eight-amino acid StrepII epitope, Plant Mol Biol, 55, 135, 2004.
176. Maxim, G. et al., Smallpox subunit vaccine produced in planta confers protection in mice, Proc Natl Acad Sci USA, 104, 6864, 2007.
177. Pérez Filgueira, D.M. et al., Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8 produced in plants using a TMV-based vector, Arch Virol, 149, 2337, 2004.
178. Spiegel, H. et al., Accumulation of antibody fusion proteins in the cytoplasm and ER of plant cells, Plant Sci, 149, 63, 1999.
179. Peschen, D. et al., Fusion proteins comprising a Fusarium-specific antibody linked to antifungal peptides protect plants against a fungal pathogen, Nat Biotechnol, 22, 732, 2004.
180. Shpigel, E. et al., Production and purification of a recombinant human hsp60 epitope using the cellulose-binding domain in Escherichia coli, Protein Expr Purif, 14, 185, 1998.
181. Shpigel, E. et al., Immobilization of recombinant heparinase I fused to cellulose-binding domain, Biotechnol Bioeng, 65, 17, 1999.
182. Shani, Z. and Shoseyov, O., Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells, U.S. Patent, 6, 331, 416, 2001.
183. Smith, M.L. et al., Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications, Virology, 348, 475, 2006.
184. Schriebl, K. et al., Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells, Protein Expr Purif, 49, 265, 2006.
185. Obregon, P. et al., HIV-1 p24-immunoglobulin fusion molecule: A new strategy for plant-based protein production, Plant Biotechnol J, 4, 195, 2006.
186. Chargelegue, D. et al., Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants, Infect Immun, 73, 5915, 2005.
187. Waugh, D.S., Making the most of affinity tags, Trends Biotechnol, 23, 316, 2005.
188. Puig, O. et al., The tandem affinity purification (TAP) method: A general procedure of protein complex purification, Methods, 24, 218, 2001.
189. Rohila, J.S. et al., Improved tandem affinity purification tag and methods for isolation of protein heterocomplexes from plants, Plant J, 38, 172, 2004.
190. Van Leene, J. et al., A tandem affinity purification-based technology platform to study the cell cycle interactome in Arabidopsis thaliana, Mol Cell Proteomics, 6, 1226, 2007.
191. Rohila, J. et al., Protein–protein interactions of tandem affinity purification-tagged protein kinases in rice, Plant J, 46, 1, 2006.
192. Rubio, V. et al., An alternative tandem affinity purification strategy applied to Arabidopsis protein complex isolation, Plant J, 41, 767, 2005.
193. Abe, M. et al., Identification of dynamin as an interactor of rice GIGANTEA by tandem affinity purification, Plant Cell Physiol, 49, 420, 2008.
194. Nallamsetty, S. et al., Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli, Protein Sci, 14, 2964, 2005.
195. Donnelly, M.I. et al., An expression vector tailored for large-scale, high-throughput purification of recombinant proteins, Protein Expr Purif, 47, 446, 2006.
196. Kenig, M. et al., Influence of the protein oligomericity on final yield after affinity tag removal in purification of recombinant proteins, J Chromatogr A, 1101, 293, 2006.
197. Arnau, J., Lauritzen, C., and Pedersen, J., Cloning strategy, production and purification of proteins with exopeptidase-cleavable His-tags, Nat Protoc, 1, 2326, 2006.
198. Pedersen, J. et al., Removal of N-terminal polyhistidine tags from recombinant proteins using engineered aminopeptidases, Protein Expr Purif, 15, 389, 1999.
199. Feeney, B. et al., Novel protein purification system utilizing an N-terminal fusion protein and a caspase-3 cleavable linker, Protein Expr Purif, 47, 311, 2006.
200. Rais-Beghdadi, C. et al., Purification of recombinant proteins by chemical removal of the affinity tag, Appl Biochem Biotechnol, 74, 95, 1998.
201. Wood, D.W. et al., A genetic system yields self-cleaving inteins for bioseparations, Nat Biotechnol, 17, 889, 1999.
202. Wood, D.W. et al., Optimized single-step affinity purification with a self-cleaving intein applied to human acidic fibroblast growth factor, Biotechnol Prog, 16, 1055, 2000.
203. Lohaus, G. et al., Is the infiltration-centrifugation technique appropriate for the isolation of apoplastic fluid? A critical evaluation with different plant species, Physiol Plantarum, 111, 457, 2001.
204. Thommes, J. and Etzel, M., Alternatives to chromatographic separations, Biotechnol Prog, 23, 42, 2007.
205. Albertsson, P.-Å. et al., Partition of cell particles and macromolecules in polymer two-phase dystems, Adv Protein Chem, 24, 309, 1970.
206. Kula, M.R. et al., Technical aspects of extractive enzyme purification, Ann NY Acad Sci, 369, 341, 1981.
207. Albertsson, P.-Å., Partition between polymer phases, J Chromatogr A, 159, 111, 1978.
208. Zhang, C. et al., Purification and stabilization of ricin B from tobacco hairy root culture medium by aqueous two-phase extraction, J Biotechnol, 117, 39, 2005.
209. Benavides, J. et al., Rotavirus-like particles primary recovery from insect cells in aqueous two-phase systems, J Chromatogr B, 842, 48, 2006.
210. Negrete, A., Ling, T.C., and Lyddiatt, A., Aqueous two-phase recovery of bio-nanoparticles: A miniaturization study for the recovery of bacteriophage T4, J Chromatogr B, 854, 13, 2007.
211. Kim, J.Y. et al., Genetically engineered elastin-protein A fusion as a universal platform for homogeneous, phase-separation immunoassay, Anal Chem, 77, 2318, 2005.
212. Ge, X. et al., Purification of an elastin-like fusion protein by microfiltration, Biotech Bioeng, 95, 424, 2006.
213. Patel, J. et al., Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves, Transgenic Res, 16, 239, 2007.
214. Scheller, J., Leps, M., and Conrad, U., Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides, Plant Biotechnol J, 4, 243, 2006.
215. Floss, D.M. et al., Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants, Plant Biotechnol J, 6, 379, 2008.
216. Lin, M. et al., Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: Purification via inverse transition cycling, Biochem J, 398, 577, 2006.
217. Franzreb, M. et al., Protein purification using magnetic adsorbent particles, Appl Microbiol Biotechnol, 70, 505, 2006.
218. Safarik, I. and Safarikova, M., Magnetic techniques for the isolation and purification of proteins and peptides, Biomagn Res Technol, 2, 7, 2004.
219. Lang, C., Schüler, D., and Faivre, D., Synthesis of magnetite nanoparticles for bio- and nanotechnology: Genetic engineering and biomimetics of bacterial magnetosomes, Macromol Biosci, 7, 144, 2007.
220. Yoshino, T. and Matsunaga, T., Efficient and stable display of functional proteins on bacterial magnetic particles using Mms13 as a novel anchor molecule, Appl Environ Microbiol, 72, 465, 2006.
221. Boi, C., Membrane adsorbers as purification tools for monoclonal antibody purification, J Chromatogr B, 848, 19, 2007.
222. Zhou, J.X. and Tressel, T., Basic concepts in Q membrane chromatography for large-scale antibody production, Biotechnol Prog, 22, 341, 2006.
223. Knudsen, H.L. et al., Membrane ion-exchange chromatography for process-scale antibody purification, J Chromatogr A, 907, 145, 2001.
224. Zhou, X. et al., Viral clearance using disposable systems in monoclonal antibody commercial downstream processing, Biotech Bioeng, 100, 488, 2008.
225. Etzel, M. and Riordan, W., Membrane chromatography: Analysis of breakthrough curves and viral clearance, in Process Scale Bioseparations for the Biopharmaceutical Industry, Shukla, A., Etzel, M., Gadam, S. Eds., Taylor & Francis, Boca Raton, FL, 2006, p. 277.
226. Yu, D. et al., Purification of a human immunoglobulin G1 monoclonal antibody from transgenic tobacco using membrane chromatographic processes, J Chromatogr A, 1187, 128, 2008.
227. Mchughen, H. and Smyth, S., US regulatory system for genetically modified organism, rDNA or transgenic crop cultivars, Plant Biotechnol J, 6, 2, 2008.
228. Crosby, L., Commercial production of transgenic crops genetically engineered to produce pharmaceuticals: Agriculture technology already exists to address most GMP issues, Biopharm Int, 16, 60, 2003.
229. Lossl, A. et al., Inducible trans-activation of plastid transgenes: Expression of the R. eutropha phb operon in transplastomic tobacco, Plant Cell Physiol, 46, 1462, 2005.
230. Menassa, R. et al., A self-contained system for the field production of plant recombinant interleukin-10, Mol Breeding, 8, 177, 2001.
231. Martinez, A. et al., Ecdysone agonist inducible transcription in transgenic tobacco plants, Plant J, 19, 97, 1999.
232. Lamphear, B.J. et al., A corn-based delivery system for animal vaccines: An oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine, Vaccine, 22, 2420, 2004.
233. Lamphear, B.J. et al., Delivery of subunit vaccines in maize seed, J Control Release, 85, 169, 2002.
234. Stoger, E. et al., Practical considerations for pharmaceutical antibody production in different crop systems, Mol Breed, 9, 149, 2002.
235. Stoger, E. et al., Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies, Plant Mol Biol, 42, 583, 2000.
236. Moloney, M.M., Oil bodies and associated proteins as affinity matrices, U.S. Patent 6924363, 2003.
237. Ramessar, K. et al., Maize plants: An ideal production platform for effective and safe molecular pharming, Plant Sci, 174, 409, 2008.
238. Tacket, C.O. et al., Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato, Nat Med, 4, 607, 1998.
239. Tacket, C.O. et al., Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes, J Infect Dis, 182, 302, 2000.
240. Mcgarvey, P.B. et al., Expression of the rabies virus glycoprotein in transgenic tomatoes, Nat Biotechnol, 13, 1484, 1995.
241. Kruse, C. et al., Transient transformation of Wolffia columbiana by particle bombardment, Aquat Bot, 72, 175, 2002.
242. Fischer, R. et al., Towards molecular farming in the future: Using plant-cell-suspension cultures as bioreactors, Biotechnol Appl Biochem, 30, 109, 1999.
243. Vermij, P. and Waltz, E., USDA approves the first plant-based vaccine, Nature 24, 233, 2006.
244. Shaaltiel, Y. et al., Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system, Plant Biotechnol J, 5, 579, 2007.
245. Fuhrmann, M. and Hegemann, W., A synthetic gene coding for the green fluorescent protein (GFP) is a versatile reporter in Chlamydomonas reinhardtii, Plant J, 19, 353, 1999.
246. Sun, M. et al., Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast, Biotechnol Lett, 25, 1087, 2003.
247. Griesbeck, C., Kobl, I., and Heitzer, M., Chlamydomonas reinhardtii, Mol Biotechnol, 34, 213, 2006.
248. Mayfield, S.P., Franklin, S.E., and Lerner, R.A., Expression and assembly of a fully active antibody in algae, Proc Natl Acad Sci USA, 100, 438, 2003.
249. Kim, D.-H. et al., Stable integration and functional expression of flounder growth hormone gene in transformed microalga, Chlorella ellipsoidea, Mar Biotechnol, 4, 63, 2002.
250. Murphy, D.J., Improving containment strategies in biopharming, Plant Biotechnol J, 5, 555, 2007.
251. Fox, J.L., Puzzling industry response to ProdiGene fiasco, Nat Biotechnol, 21, 3, 2003.
252. Stevens, W.E. et al., Optimizing pollen confinement in maize grown for regulated products, Crop Sci, 44, 2146, 2004.
253. Rotteveel, T., Al-Ahmad, H., and Gressel, J., Assessing risks and containing or mitigating gene flow of transgenic and non-transgenic phytoremediating plants, in Phytoremediation Rhizoremediation, Mackova, Martina; Dowling, David; Macek, Tomas, Eds., Springer, Dordrecht, the Netherlands, 2006, p. 259.
254. Al-Ahmad, H. and Gressel, J., Transgene containment using cytokinin-reversible male sterility in constitutive, gibberellic acid–insensitive (Δgai) transgenic tobacco, J Plant Growth Regul, 24, 19, 2005.
255. Mariani, C. et al., Induction of male-sterility in plants by a chimeric ribonuclease gene, Nature, 347, 737, 1990.
256. Schmülling, T. et al., Restoration of fertility by antisense RNA in genetically engineered male sterile tobacco plants, Mol Gen Genet, 237, 385, 1993.
257. Wang, T. et al., Low frequency transmission of a plastid-encoded trait in Setaria italica, Theor Appl Genet, 108, 315, 2004.
258. Al-Ahmad, H., S. Galili, and Gressel, J., Tandem constructs to mitigate transgene persistence: tobacco as a model, Mol Ecol, 13, 697, 2004.
259. Oliver, M. et al., Seed-based strategies for transgene containment, in Proceedings 8th International Symposium on the Biosafety of Genetically Modified Organisms, Montpellier, France, p. 154, 2004.
260. Kuvshinov, V., Anissimov, A., and Yahya, B.M., Barnase gene inserted in the intron of GUS-a model for controlling transgene flow in host plants, Plant Sci, 167, 173, 2004.
261. Kuvshinov, V. et al., Molecular control of transgene escape from genetically modified plants, Plant Sci, 160, 517, 2001.
262. Spök, A. et al., Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants, Trends Biotechnol, 26, 506, 2008.
263. Phoolcharoen, W. et al., Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana, Plant Biotechnol J, In press, 2011.
264. Chen, Q. et al., Geminiviral vector based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Human Vaccines, 7, 3, 2011.